Goodwin Procter advised HIBio on the deal while Orrick represented MorphoSys.HIBio announced its equity participation agreement and license agreements with MorphoSys AG (FSE: MOR; NASDAQ: MOR). Under…
HIBio’s License Agreements with MorphoSys AG


Goodwin Procter advised HIBio on the deal while Orrick represented MorphoSys.HIBio announced its equity participation agreement and license agreements with MorphoSys AG (FSE: MOR; NASDAQ: MOR). Under…
…